29 September 2019 |

Arbitration considerations for life science companies

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

DNA helix
Life sciences & healthcare

Termination, force majeure and frustration – international perspectives on the life sciences sector

17 April 2020
QUICK READ

by Evelyne Friedel

Click here to find out more